ONMD Company Profile and Key Details

OneMedNet Corporation last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.76. This means the shares are trading below this model’s fair value.

ONMD has shown weak momentum, losing -21.07% over the past week and -59.15% over the past quarter, though year-to-date performance is down -15.33%. Short-term trend indicators are bullishly aligned (SMA20 1.22%, SMA50 -26.12%, SMA200 -31.39%). The stock’s 14-day RSI is 44.19 (neutral), while the ATR of 0.09 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -83.28% below its high and over 135.13% above its low. Average 10-day trading volume of 299.53 thousand shares is below the 3-month average of 4.10 million, indicating normal recent market interest.

OneMedNet Corporation has 46.28 million shares outstanding. The public float is 25.60 million shares, elevated short interest at 3.57% of float. This equals 994.69 thousand shares. The short ratio is 3.91 days. Institutional investors hold 20.58% of the float. Insiders own 46.68%. Kosasa Thomas holds 15.74 million shares, Yu Jeffrey has 7.08 million shares and Green Aaron has 1.80 million shares. Over the past six months, insider transactions show net selling. They sold 126.32 thousand shares across 2 transactions.

OneMedNet Corporation (NASDAQ:ONMD) closed at $0.93 USD, gaining $0.09 (10.23%) from the previous close of $0.84. The stock is currently mid-range between its 52-week high and low $0.30 and $4.22. With a market capitalization of about $30.49 million, OneMedNet Corporation is classified as a micro-cap and shows market-like volatility (beta ~1.08). Key stats such as the average daily volume over the past year has been around 4.01 million shares, volume is running light vs its 52-week average. Headquartered in Eden Prairie, MN, OneMedNet Corporation operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Aaron Green, the company employs approximately 22 people and listed since June 24, 2021. OneMedNet Corporation provides clinical imaging solutions.

OneMedNet Corporation trades at a P/E ratio of -14.79, slightly below the S&P 500 average, with a price-to-sales ratio of 22.44 and a price-to-book ratio of -13.97 indicating negative book value, which may reflect financial stress. The P/FCF stands at -4.06, also below market averages.

Our AI price prediction model suggests that OneMedNet Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 4.3%, with price expected at $0.97 by April 16, 2026, within a range of $0.88 to $1.05 3-Month Outlook: Projected fall of -80.65%, reaching $0.18 by July 01, 2026, with a range of $0.08 to $0.24. 1-Year Outlook: Projected gain of 210.75%, with price at $2.89 by April 02, 2027, within a range of $0.00 to $3.01.

OneMedNet Corporation (NASDAQ:ONMD) shares are down -15.33% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows OneMedNet Corporation trading at a premium to the broader market with a P/E of -14.79. Our AI forecast model points to short-term strength (4.3% over two weeks), a medium-term fall (-80.65% over three months), and a longer-term gain (210.75% over one year), with expected trading ranges indicating moderate volatility.